Abstract

The first step in glutamine catabolism is catalysis by the mitochondrial enzyme glutaminase, with a specific isoform, glutaminase C (GAC), being highly expressed in cancer cells. GAC activation requires the formation of homotetramers, promoted by anionic allosteric activators such as inorganic phosphate. This leads to the proper orientation of a flexible loop proximal to the dimer-dimer interface that is essential for catalysis (i.e. the "activation loop"). A major class of allosteric inhibitors of GAC, with the prototype being bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) and the related molecule CB-839, binds to the activation loop and induces the formation of an inactive tetramer (two inhibitors bound per active tetramer). Here we describe a direct readout for monitoring the dynamics of the activation loop of GAC in response to these allosteric inhibitors, as well as allosteric activators, through the substitution of phenylalanine at position 327 with tryptophan (F327W). The tryptophan fluorescence of the GAC(F327W) mutant undergoes a marked quenching upon the binding of BPTES or CB-839, yielding titration profiles that make it possible to measure the binding affinities of these inhibitors for the enzyme. Allosteric activators like phosphate induce the opposite effect (i.e. fluorescence enhancement). These results describe direct readouts for the binding of the BPTES class of allosteric inhibitors as well as for inorganic phosphate and related activators of GAC, which should facilitate screening for additional modulators of this important metabolic enzyme.

Highlights

  • The first step in glutamine catabolism is catalysis by the mitochondrial enzyme glutaminase, with a specific isoform, glutaminase C (GAC), being highly expressed in cancer cells

  • Because GAC is often highly expressed in cancer cells, it has been described as a “gatekeeper” enzyme for the elevated glutamine metabolism exhibited by these cells (“glutamine addiction”)

  • Prior studies of the structure-function relationships of glutaminases have revealed their essential role in glutamine metabolism within mammalian cells, where their activity is governed by their self-association to form tetramers [28, 32,33,34,35]

Read more

Summary

Direct assay for allosteric modulators of glutaminase

BPTES, and showed it to be effective against triple-negative breast cancer cells. CB-839 efficacy has been examined in vivo and subsequently tested in clinical trials [23]. Elucidation of the binding site of BPTES, based on the X-ray crystal structure solved for the inhibitor bound to the KGA/GAC enzymes, revealed that its interactions with a flexible loop within the dimer-dimer interface of the tetrameric forms of these enzymes (i.e. the “activation loop”), accounted for its mode of inhibition. Mutations along this loop (316KEPSGLRFNKLF327) can markedly impact enzyme activity. This tryptophan reporter group provides a real-time assay for the direct binding of allosteric activators such as inorganic phosphate and offers strong evidence for the distinct conformational changes induced within the activation loop by activators versus inhibitors

Results
BPTES requires tetramer formation to bind to GAC
Inorganic phosphate binds to the tetrameric state of GAC
Discussion
Preparation of recombinant GAC
Protein labeling with FRET pairs
MALS analysis
Glutaminase assays
Fluorescence measurements
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call